Literature DB >> 15090778

Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study.

Ludo Lavreys1, Jared M Baeten, Harold L Martin, Julie Overbaugh, Kishorchandra Mandaliya, Jeckoniah Ndinya-Achola, Joan K Kreiss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15090778     DOI： 10.1097/00002030-200403050-00017

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  33 in total

1.  Hormonal contraception and area of cervical ectopy: a longitudinal assessment.

Authors:  Patricia L Bright; Abigail Norris Turner; Charles S Morrison; Emelita L Wong; Cynthia Kwok; Irina Yacobson; Rachel A Royce; Heidi O Tucker; Paul D Blumenthal
Journal:  Contraception       Date:  2011-03-23       Impact factor: 3.375

2.  HIV infection and AIDS among young women in South Africa.

Authors:  Adamson S Muula
Journal:  Croat Med J       Date:  2008-06       Impact factor: 1.351

3.  Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.

Authors:  Jennifer E Balkus; Elizabeth R Brown; Sharon L Hillier; Anne Coletti; Gita Ramjee; Nyaradzo Mgodi; Bonus Makanani; Cheri Reid; Francis Martinson; Lydia Soto-Torres; Salim S Abdool Karim; Zvavahera M Chirenje
Journal:  Contraception       Date:  2015-10-28       Impact factor: 3.375

4.  Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.

Authors:  Jessica L Castilho; Cathy A Jenkins; Bryan E Shepherd; Sally S Bebawy; Megan Turner; Timothy R Sterling; Vlada V Melekhin
Journal:  J Womens Health (Larchmt)       Date:  2015-03-09       Impact factor: 2.681

5.  Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.

Authors:  Michelle C Sabo; Barbra A Richardson; Ludo Lavreys; Harold L Martin; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

6.  Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Authors:  Chelsea B Polis; Sharon J Phillips; Sharon L Hillier; Sharon L Achilles
Journal:  AIDS       Date:  2016-11-13       Impact factor: 4.177

Review 7.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

8.  Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Authors:  Elizabeth M Stringer; Mark Giganti; Rosalind J Carter; Wafaa El-Sadr; Elaine J Abrams; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2009-11       Impact factor: 4.177

Review 9.  Dendritic cells and vaccine design for sexually-transmitted diseases.

Authors:  Dorothee Duluc; Julien Gannevat; Hyemee Joo; Ling Ni; Katherine Upchurch; Muriel Boreham; Michael Carley; Jack Stecher; Gerard Zurawski; Sangkon Oh
Journal:  Microb Pathog       Date:  2012-11-29       Impact factor: 3.738

10.  Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.

Authors:  Kristina Abel; Tracy Rourke; Ding Lu; Kristen Bost; Michael B McChesney; Christopher J Miller
Journal:  J Infect Dis       Date:  2004-09-24       Impact factor: 5.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.